Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026Transcranial Magnetic Stimulator Market (By Type: dTMS, rTMS, Others; By Application: Depression, Epilepsy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The global transcranial magnetic stimulator market size is accounted over USD 2.1 Billion by 2026 and growing at CAGR 9.0% during the forecast period 2019-2026.

Transcranial magnetic stimulators are widely used in the treatment of brain and neurological diseases. The transcranial magnetic stimulators is a non-invasive technique which applies magnetic pulses to the brain that uses magnetic field to reduce chronic pain and stimulate nerve cells in the brain. During last few years, the demand for the transcranial magnetic stimulators have increased significantly owing to the increasing prevalence of the various neurological diseases. Increasing awareness about health, rising population and changing lifestyle have driven the growth of the transcranial magnetic stimulator market. Many government and private organization are trying to educate the people about various application and benefits of the transcranial magnetic stimulator which have supported the growth of the transcranial magnetic stimulators market. On the other hand, limited penetration of the transcranial magnetic stimulator in developing countries in Asia and Africa, high prices may slow the growth of the transcranial magnetic stimulator market.

The market research study on “Transcranial Magnetic Stimulator Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global Transcranial magnetic stimulator market. The report also analyzes the key players operating in Transcranial magnetic stimulator market and identifies the key strategies deployed by them along with the market share of leading players.

The global Transcranial magnetic stimulator market is segmented as below:

Transcranial magnetic stimulator Market By Type

  • dTMS
  • rTMS
  • Others

Transcranial magnetic stimulator Market By Application

  • Depression
  • Epilepsy

Transcranial magnetic stimulator Market by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Sweden
    • Norway
    • Denmark
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Singapore
    • India
    • Rest of Asia-Pacific
  • Rest of the World
    • UAE
    • Qatar
    • Saudi Arabia
    • South Africa
    • Rest of the World

The key trends supporting the transcranial magnetic stimulator market growth includes increasing awareness and huge number of people suffering from mental function.

The transcranial magnetic stimulator is segmented by type and application. On the basis of type, the global transcranial magnetic stimulator is segmented into dTMS, rTMS, and others

On the basis of application, the market is segmented into depression, and epilepsy. Depression application segment is the fastest growing segment owing to the factors such as global leading cause of disability. According to the WHO, over half of with depression are receiving treatment such as medication and therapies. Additionally, changing lifestyle has led to increased the prevalence of the number of patient suffering from depression. 

Geographically, the transcranial magnetic stimulator market is segmented into North America, Europe, Asia Pacific, (LAMEA).

North America is expected to hold major market share during forecast period owing to high presence of huge patient suffering from various neurological diseases, rising geriatric population and well developed economy. Additionally, increasing number of surgeries coupled with the high healthcare spending have supported the growth of the North America transcranial magnetic stimulators market across the globe. In 2015, According to the Federal Interagency Forum, over, 15.1% populations were above 65 aged in North America. U.S. holds the major share of over 75% in North America transcranial magnetic stimulators market.

Europe is expected to second leading position in the global transcranial magnetic stimulator market. Adoption of advanced devices and treatment methods, well awareness among the people and huge patient pool are the major drivers of the transcranial magnetic stimulator market. Favorable government support and desecrating lifestyle have supported the transcranial magnetic stimulator market growth.

Asia Pacific is expected to be fastest growing market for transcranial magnetic stimulator owing to the presence of huge population suffering from neurological diseases and lifestyle such as diabetes are major diving factor in this region. Presence of rapidly developing economy, rising government support and increasing healthcare spending have boosting the growth of transcranial magnetic stimulator market in Asia Pacific. India and China holds the major share in the Asia Pacific transcranial magnetic stimulators market owing to the increasing government support and increasing spending power of the people.

The LAMEA transcranial magnetic stimulator market is majorly driven by increasing number of people suffering from brain and neurological, increasing awareness regarding availability of advanced treatment, and increasing government support. Rising geriatric population, and increasing government support have supported the growth of the transcranial magnetic stimulator market.

Some of the major players analyzed and profiles in this market include Brainsway Ltd., Nexstim Plc, Magstim, Neuronetics Inc., TMS Neurosolutions, Mag Venture, and eNeura Inc.

Being a nascent market, many new companies many enter in the market in near future which will increase the competitive rivalry. Continuously increasing demand for the advanced treatment favored the international players to withstand in the market. Additionally, price reduction strategies and introduction of technologically advanced products undertaken by key players will fuel the market growth and competition in the market.

All the major players in the market are focusing on technological advancements, launch of new types of TMS, and growth strategies, such as mergers and acquisitions.

For instance, in September 2017, eNeura Inc., received FDA approval for eNeura spring TMS.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary